A spin-out from the University of Cambridge, Akubio was founded in 2001
to develop acoustic biosensor instrumentation utilising core intellectual
property invented within the University. Resonant Acoustic Profiling (RAP)
enables the real-time detection of molecular interactions, and can be
applied in many fields.
Today, through the RAP·id 4 product range, the
company is firmly focussed on enabling molecular measurement in research,
therapy development and drug discovery research. We listen carefully to
understand the needs of scientists working in these demanding
Akubio is rapidly expanding its core capabilities in
piezoelectric devices, digital signal processing and biology as well as
The company is in the process of introducing multiple products, including
analytical instrumentation, consumable reagents and accessories.